Skip to main content

Table 4 Baseline participant characteristics from the elicitation exercise

From: Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study

Characteristic

Label

Mean (range or %)

Age (n = 21)

 

66.3 (48 to 88)

Sex (n = 21)

Female

Male

1 (5%)

20 (95%)

Ethnicity (n = 21)

White British

21 (100%)

Coronary intervention received (n = 21)

PCI

CABG

Medical Management

14 (67%)

6 (29%)

1 (5%)

DAPT exposure time (n = 21)

≤6 months

9 (43%)

> 6 months

12 (57%)

Months received DAPT (n = 20)a

 

7.5 (0 to 15)

Days since starting DAPT (n = 21)b

 

235 (18 to 561)

Reported previously experiencing a minor bleed while on DAPTc

 

10 (48%)

EQ-5D-3 L UK tariff (n = 21)

 

0.760 (0.159 to 1)

EQ-5D-3 L US tariff (n = 21)

 

0.816 (0.446 to 1)

EQ-5D-5 L UK tariff (n = 21)

 

0.824 (0.197 to 1)

EQ-5D-5 L UK crosswalk (n = 21)

 

0.760 (0.221 to 1)

EQ-5D-5 L US crosswalk (n = 21)

 

0.817 (0.440 to 1)

  1. CABG coronary artery bypass grafting, DAPT dual antiplatelet therapy, PCI percutaneous coronary intervention
  2. aThis is self-reported from the patient-demographics questionnaire; a value of zero for this variable indicates that the participant had received DAPT for less than a month
  3. bDays between the date of the focus group and the date the participant commenced DAPT therapy. The date the participant commenced DAPT therapy was derived from the screening questionnaire used during recruitment
  4. cThis information was not collected in the patient-demographics questionnaire, but rather ascertained in the discussions that occurred during the qualitative interviews that were conducted as part of a separate study using the same participant sample that completed the elicitation exercise